MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P40
Within normal range
vs 2Y Ago
-2.9x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025-67.40%
2024-171.94%
202322.98%
2022-58.72%
2021-11023.08%
20200.00%